Skip to main content
HR 4215 118th Congress House Health Asia Australia Canada Civil actions and liability Europe France Germany Health care costs and insurance Health care coverage and access Inflation and prices Italy Japan Medicaid Medical research Medicare Military medicine Netherlands North America Oceania

End Price Gouging for Medications Act

Introduced: June 20, 2023 Introduced by: Dingell, Debbie Democratic · Michigan See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 19, 2023
Referred to the Subcommittee on Health.
Jun 23, 2023
Referred to the Subcommittee on Health.
Jun 20, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Accountability, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 20, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.

Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 2044 Identical bill End Price Gouging for Medications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 9
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4215: End Price Gouging for Medications Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4215/
MLA
"H.R. 4215: End Price Gouging for Medications Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4215/.
Bluebook (legal)
H.R. 4215, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4215/.
Markdown link
[H.R. 4215: End Price Gouging for Medications Act](https://openamerica.io/bill/118-HR-4215/)
Report a problem